Chagas Cardiomyopathy

Chagas, 1909, Nova trypanozomiaze humana, Mem Inst Oswaldo Cruz, 1, 159, 10.1590/S0074-02761909000200008

Kirchhoff, 1993, American trypanosomiasis (Chagas' disease)–a tropical disease now in the United States, N Engl J Med, 329, 639, 10.1056/NEJM199308263290909

Schmunis, 2007, Epidemiology of Chagas disease in non-endemic countries: the role of international migration, Mem Inst Oswaldo Cruz, 102, 75, 10.1590/S0074-02762007005000093

Schmunis, 2010, Chagas disease: a Latin American health problem becoming a world health problem, Acta Trop, 115, 14, 10.1016/j.actatropica.2009.11.003

Hotez, 2012, Chagas disease: “the new HIV/AIDS of the Americas”, PLoS Negl Trop Dis, 6, e1498, 10.1371/journal.pntd.0001498

Shikanai-Yasuda, 2012, Oral transmission of Chagas disease, Clin Infect Dis, 54, 845, 10.1093/cid/cir956

Dias, 2015, Evolution of Chagas disease screening programs and control programs: historical perspective, Glob Heart, 10, 193, 10.1016/j.gheart.2015.06.003

WHO, 2002, 64

WHO, 2012, Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis, 11

World Health Organization, 2015, Chagas disease in Latin America: an epidemiological update based on 2010 estimates, Wkly Epidemiol Rec, 90, 33

Gascon, 2010, Chagas disease in Spain, the United States and other non-endemic countries, Acta Trop, 115, 22, 10.1016/j.actatropica.2009.07.019

CDC, 2013

Stanaway, 2015, The burden of Chagas disease, Glob Heart, 10, 139, 10.1016/j.gheart.2015.06.001

2015, Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet, 385, 117, 10.1016/S0140-6736(14)61682-2

Murray, 2015, Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition, Lancet, 386, 2145, 10.1016/S0140-6736(15)61340-X

Lee, 2013, Global economic burden of Chagas disease: a computational simulation model, Lancet Infect Dis, 13, 342, 10.1016/S1473-3099(13)70002-1

Bonney, 2008, Chagas heart disease pathogenesis: one mechanism or many?, Curr Mol Med, 8, 510, 10.2174/156652408785748004

Tanowitz, 2015, Developments in the management of Chagas cardiomyopathy, Expert Rev Cardiovasc Ther, 13, 1393, 10.1586/14779072.2015.1103648

Marin-Neto, 2007, Pathogenesis of chronic Chagas heart disease, Circulation, 115, 1109, 10.1161/CIRCULATIONAHA.106.624296

Sabino, 2015, Detection of Trypanosoma cruzi DNA in blood by PCR is associated with Chagas cardiomyopathy and disease severity, Eur J Heart Fail, 17, 416, 10.1002/ejhf.220

Schijman, 2004, Trypanosoma cruzi DNA in cardiac lesions of Argentinean patients with end-stage chronic Chagas heart disease, Am J Trop Med Hyg, 70, 210, 10.4269/ajtmh.2004.70.210

Zhang, 1999, Parasite persistence correlates with disease severity and localization in chronic Chagas' disease, J Infect Dis, 180, 480, 10.1086/314889

Machado, 2013, Pathogenesis of Chagas cardiomyopathy: role of inflammation and oxidative stress, J Am Heart Assoc, 2, e000539, 10.1161/JAHA.113.000539

Machado, 2012, Pathogenesis of Chagas disease: time to move on, Front Biosci (Elite Ed), 4, 1743, 10.2741/e495

Dutra, 2014, Immunoregulatory networks in human Chagas disease, Parasite Immunol, 36, 377, 10.1111/pim.12107

Cunha-Neto, 2011, Autoimmunity, Adv Parasitol, 76, 129, 10.1016/B978-0-12-385895-5.00006-2

Junqueira Junior, 1992, Cardiac autonomic dysfunction and neuroganglionitis in a rat model of chronic Chagas' disease, Cardiovasc Radiol, 26, 324, 10.1093/cvr/26.4.324

Oliveira, 2002, The Valsalva maneuver in Chagas disease patients without cardiopathy, Int J Control, 82, 49

Ribeiro, 2005, Vagal dysfunction in Chagas disease, Int J Control, 103, 225

Miranda, 2011, Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy, J Nucl Med, 52, 504, 10.2967/jnumed.110.082032

Marin-Neto, 2013, Pathogenesis of chronic Chagas cardiomyopathy: the role of coronary microvascular derangements, Rev Soc Bras Med Trop, 46, 536, 10.1590/0037-8682-0028-2013

Ribeiro, 1998, Indeterminate form of Chagas disease: considerations about diagnosis and prognosis, Rev Soc Bras Med Trop, 31, 301, 10.1590/S0037-86821998000300008

Andrade, 2011, Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy, Arq Bras Cardiol, 96, 434, 10.1590/S0066-782X2011000600002

Laranja, 1956, Chagas' disease; a clinical, epidemiologic, and pathologic study, Circulation, 14, 1035, 10.1161/01.CIR.14.6.1035

Laranja, 1948, Clínica e terapêutica da Doença de Chagas, Mem Inst Oswaldo Cruz, 46, 57, 10.1590/S0074-02761948000200006

Reunião de Pesquisa Aplicada em Doença de Chagas, 1985, Validade do conceito de forma indeterminada da doença de Chagas, Rev Soc Bras Med Trop, 18, 1

Gallo, 1975, Abnormal heart rate responses during exercise in patients with Chagas' disease, Cardiology, 60, 147, 10.1159/000169713

Pereira, 1984, Exercise testing in the latent phase of Chagas' disease, Clin Cardiol, 7, 261, 10.1002/clc.4960070503

Arreaza, 1983, Radionuclide evaluation of left-ventricular function in chronic Chagas' cardiomyopathy, J Nucl Med, 24, 563

Marin-Neto, 1998, Cardiac autonomic impairment and early myocardial damage involving the right ventricle are independent phenomena in Chagas' disease, Int J Cardiol, 65, 261, 10.1016/S0167-5273(98)00132-6

Sousa, 1988, Systolic and diastolic dysfunction in the indeterminate, digestive and chronic cardiac forms of Chagas' disease, Arq Bras Cardiol, 50, 293

Ortiz, 1987, Segmental contractility changes in the indeterminate form of Chagas' disease. Echocardiographic study, Arq Bras Cardiol, 49, 217

Barros, 2001, Doppler tissue imaging to evaluate early myocardium damage in patients with undetermined form of Chagas' disease and normal echocardiogram, Echocardiography, 18, 131, 10.1046/j.1540-8175.2001.00131.x

Ribeiro, 2000, A narrow QRS does not predict a normal left ventricular function in Chagas' disease, Pacing Clin Electrophysiol, 23, 2014, 10.1111/j.1540-8159.2000.tb07076.x

Acquatella, 2007, Echocardiography in Chagas heart disease, Circulation, 115, 1124, 10.1161/CIRCULATIONAHA.106.627323

Dias, 1989, The indeterminate form of human chronic Chagas' disease. A clinical epidemiological review, Rev Soc Bras Med Trop, 22, 147, 10.1590/S0037-86821989000300007

Sabino, 2013, Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors, Circulation, 127, 1105, 10.1161/CIRCULATIONAHA.112.123612

Nascimento, 2012, The prognostic significance of electrocardiographic changes in Chagas disease, J Electrocardiol, 45, 43, 10.1016/j.jelectrocard.2011.04.011

Nunes, 2013, Chagas disease: an overview of clinical and epidemiological aspects, J Am Coll Cardiol, 62, 767, 10.1016/j.jacc.2013.05.046

Andrade, 2011, I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary, Arq Bras Cardiol, 96, 434, 10.1590/S0066-782X2011000600002

Ribeiro, 2013, Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donors, PLoS Negl Trop Dis, 7, e2078, 10.1371/journal.pntd.0002078

Ribeiro, 2014, Electrocardiographic abnormalities in elderly Chagas disease patients: 10-year follow-up of the bambui cohort study of aging, J Am Heart Assoc, 3, e000632, 10.1161/JAHA.113.000632

Kaplinski, 2015, Sustained domestic vector exposure is associated with increased Chagas cardiomyopathy risk but decreased parasitemia and congenital transmission risk among young women in Bolivia, Clin Infect Dis, 61, 918, 10.1093/cid/civ446

Marcolino, 2015, Electrocardiogram and Chagas disease: a large population database of primary care patients, Glob Heart, 10, 167, 10.1016/j.gheart.2015.07.001

Sarabanda, 2005, Ventricular tachycardia in Chagas' disease: a comparison of clinical, angiographic, electrophysiologic and myocardial perfusion disturbances between patients presenting with either sustained or nonsustained forms, Int J Control, 102, 9

Paixão, 2009, Chagas disease: independent risk factor for stroke, Stroke, 40, 3691, 10.1161/STROKEAHA.109.560854

Oliveira-Filho, 2005, Chagas disease is an independent risk factor for stroke: baseline characteristics of a Chagas disease cohort, Stroke, 36, 2015, 10.1161/01.STR.0000177866.13451.e4

Nunes, 2009, Ischemic cerebrovascular events in patients with Chagas cardiomyopathy: a prospective follow-up study, J Neurol Sci, 278, 96, 10.1016/j.jns.2008.12.015

Strauss, 2011, ECG scar quantification correlates with cardiac magnetic resonance scar size and prognostic factors in Chagas' disease, Heart, 97, 357, 10.1136/hrt.2010.210047

Pierimarchi, 2013, Rapid Chagas diagnosis in clinical settings using a multiparametric assay, Diagn Microbiol Infect Dis, 75, 381, 10.1016/j.diagmicrobio.2012.12.005

Dias, 1984, Acute Chagas' disease, Mem Inst Oswaldo Cruz, 79, 85, 10.1590/S0074-02761984000500017

Viotti, 2006, Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial, Ann Intern Med, 144, 724, 10.7326/0003-4819-144-10-200605160-00006

Garcia, 2005, Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations, Antimicrob Agents Chemother, 49, 1521, 10.1128/AAC.49.4.1521-1528.2005

Viotti, 1994, Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up, Am Heart J, 127, 151, 10.1016/0002-8703(94)90521-5

Morillo, 2015, Randomized trial of benznidazole for chronic Chagas' cardiomyopathy, N Engl J Med, 373, 1295, 10.1056/NEJMoa1507574

McMurray, 2012, Eur J Heart Fail, 14, 803, 10.1093/eurjhf/hfs105

Yancy, 2013, 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, Circulation, 128, e240, 10.1161/CIR.0b013e31829e8807

Ribeiro, 2012, Diagnosis and management of Chagas disease and cardiomyopathy, Nat Rev Cardiol, 9, 576, 10.1038/nrcardio.2012.109

Botoni, 2007, A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy, Am Heart J, 153, 544.e1-8, 10.1016/j.ahj.2006.12.017

Taylor, 2004, Combination of isosorbide dinitrate and hydralazine in blacks with heart failure, N Engl J Med, 351, 2049, 10.1056/NEJMoa042934

Pitt, 1999, The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators, N Engl J Med, 341, 709, 10.1056/NEJM199909023411001

Zannad, 2011, Eplerenone in patients with systolic heart failure and mild symptoms, N Engl J Med, 364, 11, 10.1056/NEJMoa1009492

Pitt, 2003, Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction, N Engl J Med, 348, 1309, 10.1056/NEJMoa030207

Bocchi, 2001, The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology, Ann Thorac Surg, 71, 1833, 10.1016/S0003-4975(01)02587-5

Sousa, 2008, Prevention strategies of cardioembolic ischemic stroke in Chagas' disease, Arq Bras Cardiol, 91, 306, 10.1590/S0066-782X2008001700004

Barbosa, 2015, Ventricular arrhythmias in Chagas disease, Rev Soc Bras Med Trop, 48, 4, 10.1590/0037-8682-0003-2014

Barbosa, 2013, Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease, Europace, 15, 957, 10.1093/europace/eut011

Martinelli, 2014, Implantable cardioverter-defibrillator efficacy in Chagas disease patients depends not only on the device performance: optimizing the adjunct therapy is essential, Europace, 16, 939, 10.1093/europace/eut310

Hotez, 2007, Control of neglected tropical diseases, N Engl J Med, 357, 1018, 10.1056/NEJMra064142

Yamagata, 2006, Control of Chagas disease, Adv Parasitol, 61, 129, 10.1016/S0065-308X(05)61004-4

Rassi, 2006, Development and validation of a risk score for predicting death in Chagas' heart disease, N Engl J Med, 355, 799, 10.1056/NEJMoa053241

Rocha, 2006, A risk score for predicting death in Chagas' heart disease, N Engl J Med, 355, 2488, 10.1056/NEJMc062580

Salles, 2003, Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: results of a long-term follow-up study, Circulation, 108, 305, 10.1161/01.CIR.0000079174.13444.9C

Basquiera, 2003, Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction, Heart, 89, 1186, 10.1136/heart.89.10.1186

Viotti, 2004, Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure, Heart, 90, 655, 10.1136/hrt.2003.018960

Viotti, 2005, Clinical predictors of chronic chagasic myocarditis progression, Rev Esp Cardiol, 58, 1037, 10.1157/13078551

Benchimol Barbosa, 2007, Noninvasive prognostic markers for cardiac death and ventricular arrhythmia in long-term follow-up of subjects with chronic Chagas' disease, Braz J Med Biol Res, 40, 167, 10.1590/S0100-879X2006005000061

Cardinalli-Neto, 2007, Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy, J Cardiovasc Electrophysiol, 18, 1236, 10.1111/j.1540-8167.2007.00954.x

Ribeiro, 2008, Prognostic value of signal-averaged electrocardiogram in Chagas disease, J Cardiovasc Electrophysiol, 19, 502, 10.1111/j.1540-8167.2007.01088.x

Theodoropoulos, 2008, Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy, Int J Cardiol, 128, 22, 10.1016/j.ijcard.2007.11.057

Nunes, 2009, Left atrial volume provides independent prognostic value in patients with Chagas cardiomyopathy, J Am Soc Echocardiogr, 22, 82, 10.1016/j.echo.2008.11.015

Gonçalves, 2010, Mortality indicators among chronic Chagas patients living in an endemic area, Int J Cardiol, 143, 235, 10.1016/j.ijcard.2009.02.011

Lima-Costa, 2010, Chagas disease predicts 10-year stroke mortality in community-dwelling elderly: the Bambui cohort study of aging, Stroke, 41, 2477, 10.1161/STROKEAHA.110.588061

Pedrosa, 2011, Prognostic value of exercise-induced ventricular arrhythmia in Chagas' heart disease, Pacing Clin Electrophysiol, 34, 1492, 10.1111/j.1540-8159.2011.03171.x

Ribeiro, 2011, T-wave amplitude variability and the risk of death in Chagas disease, J Cardiovasc Electrophysiol, 22, 799, 10.1111/j.1540-8167.2010.02000.x

Sarabanda, 2011, Predictors of mortality in patients with Chagas' cardiomyopathy and ventricular tachycardia not treated with implantable cardioverter-defibrillators, Pacing Clin Electrophysiol, 34, 54, 10.1111/j.1540-8159.2010.02896.x

Bestetti, 2011, Effects of B-Blockers on outcome of patients with Chagas' cardiomyopathy with chronic heart failure, Int J Cardiol, 151, 205, 10.1016/j.ijcard.2010.05.033

Nunes, 2012, Different prognostic impact of the tissue Doppler-derived E/e' ratio on mortality in Chagas cardiomyopathy patients with heart failure, J Heart Lung Transplant, 31, 634, 10.1016/j.healun.2012.01.865